OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study
Debanjan Sen, Pradip Debnath, Bimal Debnath, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 2, pp. 941-962
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease
Cécilia Hognon, Marco Marazzi, Cristina García‐Iriepa
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5855-5855
Open Access | Times Cited: 10

Water‐SDS‐Ionic Liquid Catalytic System for the Synthesis of Pyrano‐chromenes and in‐silicio Approach to Predict Inhibitory Activity Against Mpro of SARS‐CoV‐2**
Abhijit Rudra Paul, Sudhan Debnath, Swapan Majumdar
ChemistrySelect (2023) Vol. 8, Iss. 4
Closed Access | Times Cited: 5

Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses
Sourodip Sengupta, Debina Bhattacharyya, Grishma Kasle, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 11

An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 Mpro Target
V. Alagarsamy, P. Shyam Sundar, Bandi Narendhar, et al.
Medicinal Chemistry (2023) Vol. 19, Iss. 9, pp. 925-938
Closed Access | Times Cited: 4

Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA
Alexandre de Fátima Cobre, Moisés Maia Neto, Eduardo Borges de Melo, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5881-5894
Closed Access | Times Cited: 4

QSAR, molecular docking, and dynamics-based computational discovery of potential PLK4 inhibitors for tumor therapy
Yuan Liu, Jian‐Bo Tong, Xuanlu Fan
Process Biochemistry (2024) Vol. 146, pp. 273-286
Closed Access | Times Cited: 1

The impact of host microRNAs on the development of conserved mutations of SARS-CoV-2
Shokoofeh Ghaemi, Asghar Abdoli, Hesam Karimi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Leveraging nature’s pharmacy: A comprehensive review of traditional medicinal and aromatic plants against COVID-19
Zeenath Banu, P. Saidaiah, Unaiza Khan, et al.
Annals of Phytomedicine An International Journal (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Glycemic index and COVID-19 management: A comprehensive review of low, medium and high glycemic inde x foods
P. Saidaiah, Zeenath Banu, Geetha Arumugam, et al.
Annals of Phytomedicine An International Journal (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Walter Filgueira de Azevedo, Gabriela Bitencourt‐Ferreira, Joana Retzke Godoy, et al.
Current Medicinal Chemistry (2021) Vol. 28, Iss. 37, pp. 7614-7633
Closed Access | Times Cited: 8

ETHNOBOTANICAL STUDY OF MEDICINAL PLANT USAGE DURING COVID-19 PANDEMIC: A COMMUNITY-BASED SURVEY IN INDONESIA
Ni Made Dwi Mara Widyani Nayaka, Putu Era Sandhi Kusuma Yuda, Dwi Arymbhi Sanjaya, et al.
BIOTROPIA (2023) Vol. 30, Iss. 2, pp. 183-194
Open Access | Times Cited: 3

In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets
V. Alagarsamy, V. Raja Solomon, Sankaranarayanan Murugesan, et al.
Current Drug Discovery Technologies (2023) Vol. 21, Iss. 3
Closed Access | Times Cited: 3

Ellagic Acid as a Potential Inhibitor against the Nonstructural Protein NS3 Helicase of Zika Virus: A Molecular Modelling Study
Malathi Kullappan, B. Anna Benedict, Anusha Rajajagadeesan, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 5

Automedicación y uso de plantas medicinales en estudiantes universitarios de la Amazonía Peruana durante la primera ola por COVID-19
Piero Pasache Pinedo, Maxzy Andrea Diaz Mena, Milagros Flórez Vela, et al.
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo (2023) Vol. 15, Iss. 4, pp. 493-502
Open Access | Times Cited: 2

Potential efficacy of existing drug molecules against severe fever with thrombocytopenia syndrome virus: an in silico study
Shilpa Chatterjee, Choon‐Mee Kim, Dong‐Min Kim
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 4

A Data Analytics-Based Study in SARS-CoV-2 Genome Revealed a Commonality in the Infection Pattern
Madhusmita Dash, V Kumar, Preetisudha Meher, et al.
Lecture notes in electrical engineering (2024), pp. 173-184
Closed Access

Exploration of Industrial, Traditional, and Pharmaceutical Applications of Diversity Rich Genus Trigonella: A Comprehensive Review
Prawal Pratap Singh Verma, Saba Siddiqui, Md. Abu Nayyer, et al.
Current Agriculture Research Journal (2024) Vol. 12, Iss. 1, pp. 63-80
Open Access

Exploring Chemical Space to Identify Partial Binders Against hMPV Nucleocapsid Protein
Monika Verma, Nikita S. Panchal, Pramod Kumar Yadav
Journal of Cellular Biochemistry (2024) Vol. 126, Iss. 1
Closed Access

Self-care interventions among the Jordanians during the COVID-19 lockdown: A cross-sectional study of community pharmacists’ observations
Isra Dmour, Khawla D. Al-Hamaideh, Safa’a Ali Al- Qudah, et al.
Journal of Applied Pharmaceutical Science (2023)
Open Access | Times Cited: 1

An Overview on Immunity Booster Foods in Coronavirus Disease (COVID-19)
Nusrat Sahiba, Ayushi Sethiya, Dinesh K. Agarwal, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 7, pp. 1251-1284
Closed Access | Times Cited: 2

Effect of natural products use prior to infection with COVID-19 on disease severity and hospitalization: A self-reported cross-sectional survey study
Refat M. Nimer, Omar F. Khabour, Samer Swedan, et al.
F1000Research (2022) Vol. 11, pp. 639-639
Open Access | Times Cited: 2

Thiazinoquinones Derivatives as Antimalarial Agents: 3D-QSAR Studies, Molecular Docking and Molecular Dynamics Simulations
Fatima En-Nahli, Assia Belhassan, Hanan Zaki, et al.
Letters in Applied NanoBioScience (2022) Vol. 12, Iss. 3, pp. 77-77
Open Access | Times Cited: 2

Carvacrol: A PLpro Inhibitor of SARS-CoV-2 Is a Natural Weapon for COVID-19
Sudhan Debnath, Bimal Debnath, Pradip Debnath
The 17th International Electronic Conference on Synthetic Organic Chemistry (2022) Vol. 15, pp. 11-11
Open Access | Times Cited: 2

Spices for taming the COVID-19 pandemic: Prospects and perspectives
Santhosh J. Eapen
Journal of Spices and Aromatic Crops (2021), pp. 1-23
Open Access | Times Cited: 2

Scroll to top